AI Verdict
INVX has stronger fundamentals based on our AI analysis.
IOBT vs INVX Fundamental Comparison
| Metric | IOBT | INVX |
|---|---|---|
| Revenue | N/A | $978.3M |
| Net Income | $-57.0M | $83.3M |
| Net Margin | N/A | 8.5% |
| ROE | -6,258.6% | 7.9% |
| ROA | -142.7% | 6.6% |
| Current Ratio | 2.01x | 4.91x |
| Debt/Equity | 18.29x | 0.02x |
| EPS | $-0.86 | $1.20 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOBT vs INVX: Frequently Asked Questions
Is IOBT or INVX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INVX has stronger fundamentals. IOBT is rated STRONG SELL (95% confidence) while INVX is rated BUY (72% confidence). This is not investment advice.
How does IOBT compare to INVX fundamentally?
IO Biotech, Inc. has ROE of -6,258.6% vs Innovex International, Inc.'s 7.9%. Net margins are N/A vs 8.5% respectively.
Which stock pays higher dividends, IOBT or INVX?
IOBT has a dividend yield of N/A or no dividend while INVX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOBT or INVX for long term?
For long-term investing, consider that IOBT has STRONG SELL rating with 95% confidence, while INVX has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOBT vs INVX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOBT vs INVX, the AI consensus favors INVX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.